SCHEMBL7006293

SCHEMBL7006293

Cc1nc2c(OCc3c(Cl)ccc(-n4cccc4CNC(=O)C=Cc4ccc(C(=O)N(C)C)cc4)c3Cl)cccn2c1Br

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7006295 1.00 BDKRB2 (0.75) BDKRB2
SCHEMBL8724015 0.87 BDKRB2 (0.60) BDKRB2
SCHEMBL8014351 0.87 BDKRB2 (0.57) BDKRB2
SCHEMBL7667830 0.87 BDKRB2 (0.57) BDKRB2
SCHEMBL7663611 0.86 BDKRB2 (0.73) BDKRB2
SCHEMBL7663606 0.86 BDKRB2 (0.73) BDKRB2
SCHEMBL1773342 0.85 BDKRB2 (1.00) BDKRB2
SCHEMBL2334555 0.85 BDKRB2 (1.00) BDKRB2
Hydrochloric Acid SCHEMBL5577170 0.85 BDKRB2 (1.00) BDKRB2
Hydrochloric Acid SCHEMBL5577169 0.85 BDKRB2 (1.00) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861243-B1 HETEROCYCLIC COMPOUNDS AS BRADYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-11-12 EP disclosed
US-6344462-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-05 US disclosed
US-6100284-A ANTIALLERGENS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-08 US disclosed
US-6008229-A TREATING ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed